Treatment of severe regurgitation of stentless aortic valve prosthesis with a self-expandable biological valve

Journal of Invasive Cardiology

Volumn 21, Issue 3, 2009, Pages

  Ussia, Gian Paolo ^a   Barbanti, Marco ^a   Tamburino, Corrado ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Aortic regurgitation; Bioprosthesis; Percutaneous

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TACROLIMUS;

AGED; ANAMNESIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; ARTICLE; BIOPROSTHESIS; CASE REPORT; CREATININE CLEARANCE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LUNG CONGESTION; MITRAL VALVE STENOSIS; PHYSICAL EXAMINATION; RHEUMATIC FEVER; SINUS RHYTHM; STENT THROMBOSIS; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; VASCULAR SUTURE;

AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; AORTIC VALVE INSUFFICIENCY; BIOPROSTHESIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; TREATMENT OUTCOME;

EID: 67649595212     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Astor BC, Kaczmarek RG, Hefflin B, Daley WR. Mortality after aortic valve replacement: Results from a nationally representative database. Ann Thorac Surg 2000;70:1939-45.
2. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular heart disease. Eur Heart J 2003;24:1231-1243.
3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. Circulation 2002;106:3006-3008.
4. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-1223.
5. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-763.
6. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. Euro Interv 2008;4:242-249.
7. Vahanian A, Alfieri O, Walther T, et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Associa- tion of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;11:1463-1470.
8. Webb JG. Transcatheter Valve in valve implants for failed prosthetic valves. Catheter Cardiovasc Interv 2007;70:765-766.
9. Walther T, Falk V, Dewey T, et al. Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. J Am Coll Cardiol 2007;50:56-60.
10. Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: The first valve in valve procedure using the Corevalve Revalving System. Catheter Cardiovasc Interv 2007;70:760-764.